BlackRock, Inc. 13D and 13G filings for Artiva Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Artiva Biotherapeutics, Inc. ARTV | BlackRock Inc. BLK | 485,727 2.000% | -759,784 (-61.00%) | Filing |
| 2025-04-23 8:14 pm Purchase | 2025-03-31 | 13G | Artiva Biotherapeutics, Inc. ARTV | BlackRock Inc. BLK | 1,245,511 5.100% | 1,245,511 (New Position) | Filing |